Antifungal Drugs Market Size, Share, and Growth Forecast, 2025 - 2032

Antifungal Drugs Market By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), Indication (Candidiasis, Aspergillosis, Dermatophytosis, Mucormycosis, Others), Route of Administration (Oral, Topical, Injectable, Others), and Regional Analysis for 2025 - 2032

ID: PMRREP11671| 193 Pages | 17 Nov 2025 | Format: PDF, Excel, PPT* | Healthcare

Market Growth and Regional Outlook Report by Persistence Market Research

Table of Content

  1. Executive Summary
    1. Global Antifungal Drugs Market Snapshot, 2025 and 2032
    2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Indication Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Key Trends
    3. Macro-economic Factors
      1. Global Sectoral Outlook
      2. Global GDP Growth Outlook
    4. COVID-19 Impact Analysis
    5. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Tool Adoption Analysis
    2. Regulatory Landscape
    3. Value Chain Analysis
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
  4. Price Analysis, 2024A
    1. Key Highlights
    2. Key Factors Impacting Deployment Costs
    3. Pricing Analysis, By Drug Class
  5. Global Antifungal Drugs Market Outlook
    1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Current Market Size (US$ Bn) Analysis and Forecast, 2025 - 2032
    3. Global Antifungal Drugs Market Outlook: Drug Class
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Drug Class, 2019 - 2024
      3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
        1. Azoles
        2. Echinocandins
        3. Polyenes
        4. Allylamines
        5. Others
      4. Market Attractiveness Analysis: Drug Class
    4. Global Antifungal Drugs Market Outlook: Indication
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Indication, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
        1. Candidiasis
        2. Aspergillosis
        3. Dermatophytosis
        4. Mucormycosis
        5. Others
      4. Market Attractiveness Analysis: Indication
    5. Global Antifungal Drugs Market Outlook: Route of Administration
      1. Introduction / Key Findings
      2. Historical Market Size (US$ Bn) Analysis, By Route of Administration, 2019 - 2024
      3. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025 - 2032
        1. Oral
        2. Topical
        3. Injectable
        4. Others
      4. Market Attractiveness Analysis: Route of Administration
  6. Global Antifungal Drugs Market Outlook: Region
    1. Key Highlights
    2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2024
    3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
      1. North America
      2. Europe
      3. East Asia
      4. South Asia and Oceania
      5. Latin America
      6. Middle East & Africa
    4. Market Attractiveness Analysis: Region
  7. North America Antifungal Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. U.S.
      2. Canada
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Candidiasis
      2. Aspergillosis
      3. Dermatophytosis
      4. Mucormycosis
      5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Topical
      3. Injectable
      4. Others
    7. Market Attractiveness Analysis
  8. Europe Antifungal Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Türkiye
      8. Rest of Europe
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Candidiasis
      2. Aspergillosis
      3. Dermatophytosis
      4. Mucormycosis
      5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Topical
      3. Injectable
      4. Others
    7. Market Attractiveness Analysis
  9. East Asia Antifungal Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. China
      2. Japan
      3. South Korea
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Candidiasis
      2. Aspergillosis
      3. Dermatophytosis
      4. Mucormycosis
      5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Topical
      3. Injectable
      4. Others
    7. Market Attractiveness Analysis
  10. South Asia & Oceania Antifungal Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. India
      2. Southeast Asia
      3. ANZ
      4. Rest of South Asia & Oceania
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Others
    5. ICurrent Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Candidiasis
      2. Aspergillosis
      3. Dermatophytosis
      4. Mucormycosis
      5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Topical
      3. Injectable
      4. Others
    7. Market Attractiveness Analysis
  11. Latin America Antifungal Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Candidiasis
      2. Aspergillosis
      3. Dermatophytosis
      4. Mucormycosis
      5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Topical
      3. Injectable
      4. Others
    7. Market Attractiveness Analysis
  12. Middle East & Africa Antifungal Drugs Market Outlook
    1. Key Highlights
    2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2024
      1. By Country
      2. By Drug Class
      3. By Indication
      4. By Route of Administration
    3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025 - 2032
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Drug Class, 2025 - 2032
      1. Azoles
      2. Echinocandins
      3. Polyenes
      4. Allylamines
      5. Others
    5. Current Market Size (US$ Bn) Analysis and Forecast, By Indication, 2025 - 2032
      1. Candidiasis
      2. Aspergillosis
      3. Dermatophytosis
      4. Mucormycosis
      5. Others
    6. Current Market Size (US$ Bn) Analysis and Forecast, By Route of Administration, 2025-2032
      1. Oral
      2. Topical
      3. Injectable
      4. Others
    7. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. Bayer AG
        1. Overview
        2. Segments and Deployments
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. GlaxoSmithKline Plc
      3. Merck & Co., Inc.
      4. Pfizer Inc.
      5. Sanofi S.A.
      6. Glenmark Pharmaceuticals Limited
      7. Alembic Pharmaceuticals Limited
      8. SCYNEXIS, Inc.
      9. Biocon Limited
      10. Cipla Limited
      11. Abbott Laboratories
      12. Astellas Pharma, Inc.
      13. Gilead Sciences, Inc.
      14. Enzon Pharmaceuticals, Inc.
      15. F2G Ltd.
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
We use cookies to improve user experience.
Google translate